221 related articles for article (PubMed ID: 31337866)
1. Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigm.
Raimondi F; Inoue A; Kadji FMN; Shuai N; Gonzalez JC; Singh G; de la Vega AA; Sotillo R; Fischer B; Aoki J; Gutkind JS; Russell RB
Oncogene; 2019 Sep; 38(38):6491-6506. PubMed ID: 31337866
[TBL] [Abstract][Full Text] [Related]
2. Activating genomic alterations in the Gs alpha gene (GNAS) in 274 694 tumors.
Tirosh A; Jin DX; De Marco L; Laitman Y; Friedman E
Genes Chromosomes Cancer; 2020 Sep; 59(9):503-516. PubMed ID: 32337806
[TBL] [Abstract][Full Text] [Related]
3. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
[TBL] [Abstract][Full Text] [Related]
4. Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes.
Casarosa P; Gruijthuijsen YK; Michel D; Beisser PS; Holl J; Fitzsimons CP; Verzijl D; Bruggeman CA; Mertens T; Leurs R; Vink C; Smit MJ
J Biol Chem; 2003 Dec; 278(50):50010-23. PubMed ID: 14522997
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled receptors control the sensitivity of cells to the morphogen Sonic Hedgehog.
Pusapati GV; Kong JH; Patel BB; Gouti M; Sagner A; Sircar R; Luchetti G; Ingham PW; Briscoe J; Rohatgi R
Sci Signal; 2018 Feb; 11(516):. PubMed ID: 29438014
[TBL] [Abstract][Full Text] [Related]
6. Cross-communication between G
Navarro G; Cordomí A; Brugarolas M; Moreno E; Aguinaga D; Pérez-Benito L; Ferre S; Cortés A; Casadó V; Mallol J; Canela EI; Lluís C; Pardo L; McCormick PJ; Franco R
BMC Biol; 2018 Feb; 16(1):24. PubMed ID: 29486745
[TBL] [Abstract][Full Text] [Related]
7. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer.
O'Hayre M; Vázquez-Prado J; Kufareva I; Stawiski EW; Handel TM; Seshagiri S; Gutkind JS
Nat Rev Cancer; 2013 Jun; 13(6):412-24. PubMed ID: 23640210
[TBL] [Abstract][Full Text] [Related]
8. Germline-Derived Gain-of-Function Variants of Gs
Miyado M; Fukami M; Takada S; Terao M; Nakabayashi K; Hata K; Matsubara Y; Tanaka Y; Sasaki G; Nagasaki K; Shiina M; Ogata K; Masunaga Y; Saitsu H; Ogata T
J Am Soc Nephrol; 2019 May; 30(5):877-889. PubMed ID: 30962325
[TBL] [Abstract][Full Text] [Related]
9. Different biochemical properties explain why two equivalent Gα subunit mutants cause unrelated diseases.
Leyme A; Marivin A; Casler J; Nguyen LT; Garcia-Marcos M
J Biol Chem; 2014 Aug; 289(32):21818-27. PubMed ID: 24982418
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsα-receptor interaction.
Thiele S; de Sanctis L; Werner R; Grötzinger J; Aydin C; Jüppner H; Bastepe M; Hiort O
Hum Mutat; 2011 Jun; 32(6):653-60. PubMed ID: 21488135
[TBL] [Abstract][Full Text] [Related]
11. Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations.
Sbai O; Monnier C; Dodé C; Pin JP; Hardelin JP; Rondard P
FASEB J; 2014 Aug; 28(8):3734-44. PubMed ID: 24830383
[TBL] [Abstract][Full Text] [Related]
12. Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals.
Katoh Y; Katoh M
Int J Oncol; 2009 Jul; 35(1):187-92. PubMed ID: 19513567
[TBL] [Abstract][Full Text] [Related]
13. Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled receptors expressed in tumors.
Huh E; Gallion J; Agosto MA; Wright SJ; Wensel TG; Lichtarge O
Proc Natl Acad Sci U S A; 2021 Dec; 118(51):. PubMed ID: 34916293
[TBL] [Abstract][Full Text] [Related]
14. GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers.
Parish AJ; Nguyen V; Goodman AM; Murugesan K; Frampton GM; Kurzrock R
Cancer; 2018 Oct; 124(20):4080-4089. PubMed ID: 30204251
[TBL] [Abstract][Full Text] [Related]
15. Obesity-Associated
Mendes de Oliveira E; Keogh JM; Talbot F; Henning E; Ahmed R; Perdikari A; Bounds R; Wasiluk N; Ayinampudi V; Barroso I; Mokrosiński J; Jyothish D; Lim S; Gupta S; Kershaw M; Matei C; Partha P; Randell T; McAulay A; Wilson LC; Cheetham T; Crowne EC; Clayton P; Farooqi IS
N Engl J Med; 2021 Oct; 385(17):1581-1592. PubMed ID: 34614324
[TBL] [Abstract][Full Text] [Related]
16. A family with congenital hypothyroidism caused by a combination of loss-of-function mutations in the thyrotropin receptor and adenylate cyclase-stimulating G alpha-protein subunit genes.
Lado-Abeal J; Castro-Piedras I; Palos-Paz F; Labarta-Aizpún JI; Albero-Gamboa R
Thyroid; 2011 Feb; 21(2):103-9. PubMed ID: 21186955
[TBL] [Abstract][Full Text] [Related]
17. Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.
Pepe S; Korbonits M; Iacovazzo D
J Endocrinol; 2019 Feb; 240(2):R21-R45. PubMed ID: 30530903
[TBL] [Abstract][Full Text] [Related]
18. Gs/Gi Regulation of Bone Cell Differentiation: Review and Insights from Engineered Receptors.
Hsiao EC; Millard SM; Nissenson RA
Horm Metab Res; 2016 Nov; 48(11):689-699. PubMed ID: 27643449
[TBL] [Abstract][Full Text] [Related]
19. A New Multisystem Disorder Caused by the Gαs Mutation p.F376V.
Biebermann H; Kleinau G; Schnabel D; Bockenhauer D; Wilson LC; Tully I; Kiff S; Scheerer P; Reyes M; Paisdzior S; Gregory JW; Allgrove J; Krude H; Mannstadt M; Gardella TJ; Dattani M; Jüppner H; Grüters A
J Clin Endocrinol Metab; 2019 Apr; 104(4):1079-1089. PubMed ID: 30312418
[TBL] [Abstract][Full Text] [Related]
20. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.
Almeida MQ; Azevedo MF; Xekouki P; Bimpaki EI; Horvath A; Collins MT; Karaviti LP; Jeha GS; Bhattacharyya N; Cheadle C; Watkins T; Bourdeau I; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2012 Apr; 97(4):E687-93. PubMed ID: 22259056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
